Tumor Macroscopic Morphology Is an Important Prognostic Factor in Predicting Chemotherapeutic Efficacy and Clinical Outcomes of Patients With Colorectal Neuroendocrine Neoplasms, One Multicenter Retrospective Cohort Study

被引:4
作者
Wang, Zhijie [1 ]
An, Ke [2 ]
Li, Rui [3 ]
Liu, Qian [1 ]
机构
[1] Chinese Acad Med Sci & Peking Union Med Coll, Dept Colorectal Surg, Natl Canc Ctr, Natl Clin Res Ctr Canc,Canc Hosp, Beijing, Peoples R China
[2] China Japan Friendship Hosp, Dept Gen Surg, Beijing, Peoples R China
[3] Beijing Hosp, Dept Gen Surg, Beijing, Peoples R China
关键词
colon; rectum; neuroendocrine tumors; morphology; endoscopy; ATYPICAL ENDOSCOPIC FEATURES; CONSENSUS GUIDELINES; MANAGEMENT; RESECTION; RECTUM; COLON;
D O I
10.3389/fendo.2021.801741
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background and AimsLocally advanced and metastatic colorectal neuroendocrine neoplasm (NEN) is a rare disease with a dismal prognosis. We aimed to explore the value of the macroscopic morphology of NENs in the management of TNM stage II-IV colorectal NENs, which has not been fully elucidated in previous reports. MethodsWe retrospectively enrolled 125 eligible patients with TNM stage II-IV colorectal NENs who were diagnosed between 2000 and 2020 from three Chinese hospitals. All were categorized into either protruding or ulcerative NEN groups through endoscopic evaluation of their macroscopic morphology. Clinicopathological data were collected and compared between the two groups. Survival analysis was performed to assess the survival outcomes between the two groups. ResultsA total of 77 and 48 patients had protruding and ulcerative NENs, respectively. Patients with ulcerative NENs had a larger median tumor size (P<0.001) and higher median Ki-67 index (P<0.001), and a larger proportion of these patients had grade G3 disease (P=0.001) and poorly differentiated neoplasms (P=0.001), as well as higher frequencies of T3 and T4 tumors (P=0.006) than patients with protruding NENs. In addition, patients with ulcerative NENs showed a much lower response to first-line chemotherapy [50% (95% CI: 27.3% - 72.7%) versus 20% (95% CI: 3.1% - 36.9%), P=0.03] and a worse 3-year progression-free survival (PFS) rate [19.7% (95% CI: 7.2% - 32.2%) versus 49.5% (95% CI: 37.5% - 61.5%), P=0.001] and 3-year overall survival (OS) rate [30.7% (95% CI: 15.6% - 45.8%) versus 76.9% (95% CI: 66.5% - 87.3%), P<0.001] than those with protruding NENs. The multivariate analysis results indicated that the macroscopic shape of NENs was an independent prognostic factor affecting both PFS (HR = 1.760, 95% CI: 1.024 - 3.026, P = 0.04) and OS (HR = 2.280, 95% CI: 1.123 - 4.628, P = 0.02). ConclusionsUlcerative NENs were more malignant and chemotherapy resistant than protruding NENs. Tumor macroscopic morphology is a valuable prognostic factor for stage II-IV colorectal NENs.
引用
收藏
页数:13
相关论文
共 30 条
[1]   Characterization of a Novel Entity of G3 (High-grade Well-differentiated) Colorectal Neuroendocrine Tumors (NET) in the SEER Database [J].
Abdel-Rahman, Omar .
AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2021, 44 (01) :43-43
[2]   The NANETS Consensus Guidelines for the Diagnosis and Management of Gastrointestinal Neuroendocrine Tumors (NETs) Well-Differentiated NETs of the Distal Colon and Rectum [J].
Anthony, Lowell B. ;
Strosberg, Jonathan R. ;
Klimstra, David S. ;
Maples, William J. ;
O'Dorisio, Thomas M. ;
Warner, Richard R. P. ;
Wiseman, Gregory A. ;
Benson, Al B., III ;
Pommier, Rodney F. .
PANCREAS, 2010, 39 (06) :767-774
[3]   Review article: the investigation and management of rectal neuroendocrine tumours [J].
Basuroy, R. ;
Haji, A. ;
Ramage, J. K. ;
Quaglia, A. ;
Srirajaskanthan, R. .
ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2016, 44 (04) :332-345
[4]   Neuroendocrine neoplasms of rectum: A management update [J].
Bertani, Emilio ;
Ravizza, Davide ;
Milione, Massimo ;
Massironi, Sara ;
Grana, Chiara Maria ;
Zerini, Dario ;
Piccioli, Alessandra Nella ;
Spinoglio, Giuseppe ;
Fazio, Nicola .
CANCER TREATMENT REVIEWS, 2018, 66 :45-55
[5]   ENETS Consensus Guidelines for the Management of Patients with Digestive Neuroendocrine Neoplasms: Colorectal Neuroendocrine Neoplasms [J].
Caplin, Martyn ;
Sundin, Anders ;
Nillson, Ola ;
Baum, Richard P. ;
Klose, Klaus J. ;
Kelestimur, Fahrettin ;
Ploeckinger, Ursula ;
Papotti, Mauro ;
Salazar, Ramon ;
Pascher, Andreas .
NEUROENDOCRINOLOGY, 2012, 95 (02) :88-97
[6]   Preinvasive colorectal lesion transcriptomes correlate with endoscopic morphology (polypoid vs. nonpolypoid) [J].
Cattaneo, Elisa ;
Laczko, Endre ;
Buffoli, Federico ;
Zorzi, Fausto ;
Bianco, Maria Antonia ;
Menigatti, Mirco ;
Bartosova, Zdena ;
Haider, Ritva ;
Helmchen, Birgit ;
Sabates-Bellver, Jacob ;
Tiwari, Amit ;
Jiricny, Josef ;
Marra, Giancarlo .
EMBO MOLECULAR MEDICINE, 2011, 3 (06) :334-347
[7]   Development of a novel scoring system based on endoscopic appearance for management of rectal neuroendocrine tumors [J].
Chen, Luohai ;
Guo, Yu ;
Zhang, Yixuan ;
Liu, Man ;
Zhang, Yu ;
Lin, Yuan ;
Chen, Min-hu ;
Chen, Jie .
ENDOSCOPY, 2021, 53 (07) :702-709
[8]   The clinical outcomes and risk factors associated with incomplete endoscopic resection of rectal carcinoid tumor [J].
Choi, Cheol Woong ;
Park, Su Bum ;
Kang, Dae Hwan ;
Kim, Hyung Wook ;
Kim, Su Jin ;
Nam, Hyeong Seok ;
Ryu, Dae Gon .
SURGICAL ENDOSCOPY AND OTHER INTERVENTIONAL TECHNIQUES, 2017, 31 (12) :5006-5011
[9]   A nation-wide retrospective epidemiological study of gastroenteropancreatic neuroendocrine neoplasms in china [J].
Fan, Jin-Hu ;
Zhang, Yu-Qing ;
Shi, Su-Sheng ;
Chen, Yuan-Jia ;
Yuan, Xing-Hua ;
Jiang, Li-Ming ;
Wang, Shao-Ming ;
Ma, Li ;
He, Yu-Tong ;
Feng, Chang-Yan ;
Sun, Xi-Bin ;
Liu, Qing ;
Deloso, Katrina ;
Chi, Yihebali ;
Qiao, You-Lin .
ONCOTARGET, 2017, 8 (42) :71699-71708
[10]   Neuroendocrine Tumors of the Appendix, Colon, and Rectum [J].
Hrabe, Jennifer .
SURGICAL ONCOLOGY CLINICS OF NORTH AMERICA, 2020, 29 (02) :267-+